PKM and Alzheimer disease: Mendelian randomization analysis revealed pantothenate’s significant prophylactic potential in AD, particularly through its inhibitory effect on Pyruvate Kinase (PKM2) nuclear translocation within microglial cells, which is supported by previous findings of diminished vitamin B5 (pantothenate) levels in inflammatory neurological conditions [114].